Quantcast
Tag archive for ‘Bexsero’
By The Dispatch On Tuesday, July 29th, 2014
0 Comments

Bexsero, meningitis B vaccine vaccination campaign results released

Novartis has announced the initial results of a large-scale vaccination campaign with Bexsero® (Meningococcal Group B Vaccine [rDNA, component, adsorbed]) to help protect against meningitis B within the Saguenay-Lac-Saint-Jean More...

By The Dispatch On Tuesday, June 17th, 2014
1 Comment

Novartis seeks FDA approval for meningitis B vaccine, Bexsero

Basel, June 17, 2014 – Novartis announced today the submission of a Biologic License Application (BLA) to the US Food and Drug Administration (FDA) for marketing approval for the use of Bexsero® (Multicomponent More...

By The Dispatch On Monday, April 7th, 2014
0 Comments

Bexsero, meningitis B vaccine, receives FDA Breakthrough Therapy designation

PRESS RELEASE Novartis announced today that Bexsero® (Meningococcal Group B Vaccine [rDNA, component, adsorbed]) has received a Breakthrough Therapy designation from the United States Food and Drug Administration More...

By Robert Herriman On Saturday, March 22nd, 2014
0 Comments

British health officials recommend Bexsero as part of routine childhood immunization schedule

The Joint Committee on Vaccination and Immunisation (JCVI) in Great Britain has recommended the inclusion of the meningitis B vaccine, Bexsero, to be part of the routine childhood immunization schedule, according More...

By Robert Herriman On Saturday, February 1st, 2014
2 Comments

UC Santa Barbara will be offering the meningitis B vaccine, Bexsero, starting Feb. 24

In a follow-up to a story one month ago, The University of California, Santa Barbara (UCSB), who has experienced four cases of meningococcal meningitis group B during a three week time frame in Nov. 2013, will More...

By Robert Herriman On Thursday, December 26th, 2013
2 Comments

The Top 10 Infectious Disease and Outbreak News stories of 2013

2013 was a year full of impactful infectious disease stories with outbreaks of diseases not before seen in humans, diseases seen in new parts of the planet and miracle stories of survivors. Drugs not approved in More...

By Robert Herriman On Thursday, December 12th, 2013
2 Comments

Princeton vaccinates 4,361 with Bexsero with one clinic day left

Princeton University said Wednesday that more than 4,300 people received the first dose of the two-dose series of the meningococcal serogroup B vaccine after three days of clinic operations. Neisseria meningitidisImage/CDC As More...

By Robert Herriman On Monday, December 9th, 2013
2 Comments

Princeton vaccinates hundreds on first day with meningitis B vaccine, Bexsero

According to Princeton University, as of  4:30 p.m today, 1,261 individuals were vaccinated to help protect against meningococcal disease caused by serogroup B bacteria. Neisseria meningitidisImage/CDC In a More...

By Robert Herriman On Tuesday, November 26th, 2013
2 Comments

CDC expert: Use of unlicensed vaccine, Bexsero, ‘highly unusual’

During a telebriefing yesterday with CDC pediatrician and meningitis expert, Dr Amanda Cohn, a couple of key questions were answered concerning the Novartis meningitis vaccine, Bexsero. Neisseria meningitidisImage/CDC When More...

By Robert Herriman On Saturday, November 23rd, 2013
2 Comments

What is Bexsero? How common is meningococcal disease serogroup B?

With the eighth case of meningococcal meningitis confirmed at Princeton University yesterday, and at least seven confirmed as Neisseria meningitis serotype B (MenB) with the most recent still pending, health officials More...

By Robert Herriman On Saturday, November 23rd, 2013
2 Comments

Princeton University reports 8th meningitis case

A Princeton University student is receiving treatment after she was diagnosed with meningitis yesterday.  The student developed symptoms Wednesday night and went to the University’s McCosh Health Center, from More...

By Robert Herriman On Monday, November 18th, 2013
1 Comment

Princeton hopes to make Bexsero available for students in December

In a follow-up to an earlier story, Princeton University announced today via email that they will be receiving the EU/Australia approved meningococcal meningitis vaccine, Bexsero, to offer to immunize students against More...

By Robert Herriman On Thursday, January 24th, 2013
1 Comment

Bexsero, first Meningitis B vaccine, receives European Commission approval

Photo/CDC/ Debora Cartagena Switzerland-based pharmaceutical and health care company, Novartis announced this week that it’s Meningitis B vaccine, Bexsero, has received approval from the European Commission More...


Recent Posts

July 10, 2020, Comments Off on

July 9, 2020, Comments Off on

July 9, 2020, Comments Off on

July 8, 2020, Comments Off on

July 6, 2020, Comments Off on

July 6, 2020, Comments Off on

July 3, 2020, Comments Off on

DISPATCH BLOGS

Splash Page logo 300x146 Today in History